01 Strategies

SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE OVER A HALF-BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.

Sante Ventures

Privately Held Companies

Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.

Sante Capital

Publicly Traded Securities

Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.

BioStable
Cryosa
DyaMX
Endovascular Engineering
Farapulse
Geneos Therapeutics
Glyscend
Healthcare Highways
HNI Healthcare
Iterion
Laminar
Lumos
Molecular Templates (mtem)
Remedy
02 Santé Ventures Strategy

We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.

View All Investments
03 Santé Capital Strategy

We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.